Haemonetics Cell Saver 5+ - Autologous Blood Transfusion

To Next Page

To Previous Page

P/N 53063-50, Manual Revision: B Introduction

1-5

AUTOLOGOUS BLOOD TRANSFUSION

The term, autologous blood, refers to blood derived from the same individual. An

autologous blood transfusion therefore, is one in which a patient receives his or

her own blood. The blood may have been donated earlier or salvaged from shed

blood during surgery or postoperatively. Allogeneic blood, on the other hand, is

donor blood from sources other than the patient who is receiving it.

Autologous vs.

Allogeneic

Transfusion

The advantages of autologous transfusion are well documented. The major

advantages are as follows:

! No disease transmission risk

! Reduced risk of transfusion reactions

! Minimal compatibility testing

! Reduced demand on blood bank inventory

Cell Saver

Systems and

Autologous

Transfusion

In addition to the general benefits of autologous transfusion, Cell Saver

Systems provide the following benefits:

! Portability

! Rapid setup

! Rapid return of patient’s own cells

! Reduction of net blood loss

! Removal of red cell stroma

! Removal of plasma-free hemoglobin

! Removal of anticoagulant

! Removal of activated clotting factors

! Removal of extracellular potassium

! Cost-effectiveness

! General acceptance by Jehovah’s Witnesses

Autologous blood is

now widely accepted

as the first choice for

reinfusion.

Other manuals for Haemonetics Cell Saver 5+